ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Anti-obesity effects of galacto-oligosaccharides in obese rats

Kong, Shang; Huang, Xingjun; Cao, Hua; Bai, Yan; Che, Qishi; Nie, Hong*; Su, Zhengquan*广东药学院
European Journal of Pharmacology2022-2-15DOI: 10.1016/j.ejphar.2021.174728
5被引6阅读
引用收藏
分享

摘要

Galacto-oligosaccharides (GOS) are commonly used as prebiotic with a variety of known metabolic benefits; however, whether GOS plays a protective role in obesity remains unknown. Here, we demonstrate that GOS prevented obesity in a rat model of obesity induced by a high-fat diet. Our results showed that GOS effectively slowed weight gain in diet-induced obese rats without affecting energy intake. GOS significantly suppressed the hypertrophy and hyperplasia of white adipose tissue and markedly reduced the ratio of the fat/body. Consistently, GOS significantly improved serum total cholesterol, triglycerides, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol levels, indicating the weight loss activity of GOS. Interestingly, GOS also significantly increased the expression levels of browning proteins, including uncoupling protein 1, peroxisome proliferator-activated receptor-gamma, peroxisome proliferator-activated receptor-gamma coactivator 1 alpha, and PR domain 16, in both white and brown adipose tissue. Furthermore, we found that GOS markedly increased the expression levels of liver X receptor alpha, peroxisome proliferation-activated receptor-alpha, low-density lipoprotein receptor, and cholesterol 7 alpha-hydroxylase proteins in the liver of obese rats. Taken together, we concluded that GOS inhibits obesity by accelerating the browning of white fat cells and the thermogenesis of brown fat cells and that GOS improves host lipid homeostasis by promoting cholesterol catabolism.

学科与关键词

关键词
ObesityGalacto-oligosaccharidesBrowningThermogenesisLipid metabolism
相关
加载中…
  • GOS Ameliorates Nonalcoholic Fatty Liver Disease Induced by High Fat and High Sugar Diet through Lipid Metabolism and Intestinal Microbes
    Qiu, Shuting; Chen, Jiajia; Bai, Yan; He, Jincan; Cao, Hua; Che, Qishi; Guo, Jiao*; Su, Zhengquan*OncoImmunology, 2022, 14(13): 2749.被引 10
  • Chitosan oligosaccharide activates brown adipose tissue by modulating the gut microbiota and bile acid pathways based on faecal microbiota transplantation
    Lun, Weijun; Zhou, Jingwen; Bai, Yan; Che, Qishi; Cao, Hua; Guo, Jiao*; Su, Zhengquan*Journal of Functional Foods, 2023, 108: 105731.
  • Anti-Obesity Effect and Mechanism of Chitooligosaccharides Were Revealed Based on Lipidomics in Diet-Induced Obese Mice
    Zhou, Minchuan; Huang, Jingqing; Zhou, Jingwen; Zhi, Cuiting; Bai, Yan; Che, Qishi; Cao, Hua; Guo, Jiao*; Su, Zhengquan*MOLECULES, 2023, 28(14): 5595.
查看全部 →

发表信息

论文状态
公开发表
期刊
European Journal of Pharmacology
发表日期
2022-02-15
卷期
第 917 卷
页码
174728
DOI
10.1016/j.ejphar.2021.174728
语言
ENGLISH
期刊等级
3区
成果收录
SCIE

作者

  • K

    Kong, Shang (第一作者)

  • H

    Huang, Xingjun

    guangdong pharmaceut univ · new

查看全部 7 位作者收起作者
  • C

    Cao, Hua

    guangdong pharmaceut univ

  • B

    Bai, Yan

  • C

    Che, Qishi

  • N

    Nie, Hong (通讯)

  • S

    Su, Zhengquan (通讯)

    guangdong pharmaceut univ · new

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417